Recanalization and clinical outcome of occlusion sites at Baseline CT angiography in the interventional management of stroke II trial

Radiology

Volumn 273, Issue 1, 2014, Pages 202-210

  Demchuk, Andrew M ^a   Goyal, Mayank ^a   Yeatts, Sharon D ^b   Carrozzella, Janice ^c   Foster, Lydia D ^b   Qazi, Emmad ^a   Hill, Michael D ^a   Jovin, Tudor G ^d   Ribo, Marc ^e   Yan, Bernard ^f   Zaidat, Osama O ^g   Frei, Donald ^h   Von Kummer, Rüdiger ⁱ   Cockroft, Kevin M ^j   Khatri, Pooja ^c   Liebeskind, David S ^k   Tomsick, Thomas A ^c   Palesch, Yuko Y ^b   Broderick, Joseph P ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h Colorado Neurologic Inst ^*  (United States)

ⁱ UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^j PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; BRAIN ANGIOGRAPHY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOVASCULAR SURGERY; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MORTALITY; PHASE 3 CLINICAL TRIAL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL ANGIOGRAPHY; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84908664180     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14132649     Document Type: Article

References (24)

1. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368 (10) : 893-903.
2. Khatri P, Hill MD, Palesch YY, et al. Methodology of the Interventional Management of Stroke III trial. Int J Stroke 2008; 3 (2) : 130-137.
3. De Silva DA, Brekenfeld C, Ebinger M, et al. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2010; 41 (2) : 295-299.
4. Dzialowski I, Puetz V, Buchan AM, Demchuk AM, Hill MD; Calgary Stroke Program. Does the application of x-ray contrast agents impair the clinical effect of intravenous recombinant tissue-Type plasminogen activator in acute ischemic stroke patients? Stroke 2012; 43 (6) : 1567-1571.
5. Dehmer GJ, Gresalfi N, Daly D, Oberhardt B, Tate DA. Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-Type plasminogen activator in the presence of radiographic contrast agents. J Am Coll Cardiol 1995; 25 (5) : 1069-1075.
6. Pislaru S, Pislaru C, Szilard M, Arnout J, Van De Werf F. In vivo effects of contrast media on coronary thrombolysis. J Am Coll Cardiol 1998; 32 (4) : 1102-1108.
7. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32 (1) : 78-86.
8. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38 (3) : 948-954.
9. Zangerle A, Kiechl S, Spiegel M, et al. Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications. Neurology 2007; 68 (1) : 39-44.
10. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke 2010; 41 (10) : 2254-2258.
11. Hirano T, Sasaki M, Mori E, et al. Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients: Exploratory analysis of the Japan Alteplase Clinical Trial II. Stroke 2010; 41 (12) : 2828-2833.
12. Linfante I, Llinas RH, Selim M, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002; 33 (8) : 2066-2071.
13. Saarinen JT, Sillanpää N, Rusanen H, et al. The mid-M1 segment of the middle cerebral artery is a cutoff clot location for good outcome in intravenous thrombolysis. Eur J Neurol 2012; 19 (8) : 1121-1127.
14. Paciaroni M, Balucani C, Agnelli G, et al. Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: The ICARO study. Stroke 2012; 43 (1) : 125-130.
15. Mokin M, Kass-Hout T, Kass-Hout O, et al. Intravenous thrombolysis and endovascular therapy for acute ischemic stroke with internal carotid artery occlusion: A systematic review of clinical outcomes. Stroke 2012; 43 (9) : 2362-2368.
16. Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS; MERCI and Multi MERCI Writing Committee. Mechanical thrombectomy of intracranial internal carotid occlusion: Pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007; 38 (4) : 1274-1280.
17. Toyota S, Sugiura S, Iwaisako K. Simultaneous combined intravenous recombinant tissue plasminogen activator and endovascular therapy for hyperacute middle cerebral artery M1 occlusion. Interv Neuroradiol 2011; 17 (1) : 115-122.
18. Cohen JE, Rabinstein AA, Ramirez-de-Noriega F, et al. Excellent rates of recanalization and good functional outcome after stentbased thrombectomy for acute middle cerebral artery occlusion. Is it time for a paradigm shift? J Clin Neurosci 2013; 20 (9) : 1219-1223.
19. Wardlaw JM, von Kummer R, Carpenter T, et al. Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke. Int J Stroke 2013 Jan 22. [Epub ahead of print]
20. Morais LT, Leslie-Mazwi TM, Lev MH, Albers GW, Yoo AJ. Imaging-based selection for intra-Arterial stroke therapies. J Neurointerv Surg 2013; 5 (Suppl 1) : I13-i20.
21. Demchuk AM, Menon B, Goyal M. Imagingbased selection in acute ischemic stroke trials -A quest for imaging sweet spots. Ann N Y Acad Sci 2012; 1268: 63-71.
22. Abou-Chebl A, Lin R, Hussain MS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: Preliminary results from a retrospective, multicenter study. Stroke 2010; 41 (6) : 1175-1179.
23. Mazighi M, Chaudhry SA, Ribo M, et al. Impact of onset-To-reperfusion time on stroke mortality: A collaborative pooled analysis. Circulation 2013; 127 (19) : 1980-1985.
24. Jayaraman MV, Grossberg JA, Meisel KM, Shaikhouni A, Silver B. The clinical and radiographic importance of distinguishing partial from near-complete reperfusion following intra-Arterial stroke therapy. AJNR Am J Neuroradiol 2013; 34 (1) : 135-139.